eCTD 4.0 -

January 5, 2026
Medicinal Products,
Publishing and Submission
Japan PMDA eCTD Best Practices for 2026 Submissions: A Practical, Submission-Ready Guide for Regulatory Teams
December 9, 2025
Medicinal Products,
Publishing and Submission
What Life Sciences Companies Need to Know About Japan’s Transition to eCTD 4.0
December 9, 2025
Medicinal Products,
Publishing and Submission
Step-by-Step Guide for Preparing a Renewal Dossier in eCTD Format (2026)
December 9, 2025
Medicinal Products,
Publishing and Submission
Best Compliance Practices in Regulatory Publishing & Submissions: A 2026 Global Readiness Guide for Life Sciences
November 18, 2025
Medicinal Products,
Regulatory Affairs
Japan Pharma Market: Leading APAC’s Digital Regulatory Evolution
April 18, 2025
freya fusion
Key Updates on TGA’s eCTD 4.0 Rollout
March 19, 2025
Medicinal Products,
Publishing and Submission
What Life Sciences Companies Need to Know about Japan’s Transition to eCTD 4.0
March 7, 2025
freya fusion
EMA’s Roadmap for eCTD 4.0 - Key Updates and Insights
February 6, 2025
freya fusion
The Future of Regulatory Submissions: Trends to Watch in 2025
January 16, 2025
freya fusion
USFDA's eCTD 4.0 Update: Key Takeaways
September 5, 2024
Medicinal Products,
Publishing and Submission - Pillar
Interview Your eCTD 4.0
January 9, 2024
Medicinal Products,
Publishing and Submission
The Importance of Lifecycle Enhancements and Study Tagging in eCTD 4.0